インスリン保存装置の市場規模、シェア、成長分析、製品タイプ別、患者タイプ別、地域別 - 産業予測、2025年～2032年

インスリン保存装置 2023年の市場規模は10億米ドルで、予測期間（2025年～2032年）のCAGRは7.7%で、2024年の10億8,000万米ドルから2032年には19億5,000万米ドルに成長する見通しです。

同市場は、糖尿病有病率の上昇と高度なインスリン送達デバイスの採用拡大により、力強い成長を遂げています。この市場拡大の大きなきっかけとなっているのが、信頼性の高い持ち運びオプションが必要なインスリンポンプの普及により、革新的なインスリン保存ソリューションへの需要が高まっていることです。都市化、座りがちなライフスタイル、不健康な食習慣などの要因が、糖尿病の主な原因である肥満の急増につながっており、世界肥満連盟は2030年までに全世界で10億人がこの影響を受けると予測しています。このような糖尿病患者の増加は、インスリン保存装置の需要を押し上げると思われます。特筆すべきは、1型糖尿病患者、特に20歳未満の152万人が、インスリンの効能を維持するために効果的な治療と温度に敏感な保管ソリューションを必要としていることです。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 規制情勢
• 特許分析

インスリン保存装置市場規模：製品タイプ別 & CAGR（2025年～2032年）

• 市場概要
• 断熱キット
• 電池式インスリン保存装置

インスリン保存装置市場規模：患者タイプ別 & CAGR（2025年～2032年）

• 市場概要
• 1型糖尿病
• 2型糖尿病

インスリン保存装置市場規模 & CAGR（2025年～2032年）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022年～2024年）

主要企業プロファイル

• ReadyCare, LLC（米国）
• DISONCARE（中国）
• Medicool（中国）
• Tawa Outdoor（中国）
• Cooluli（フランス）
• Arkray, Inc.（日本）
• Zhengzhou Olive Electronic Technology Co., Ltd.（中国）
• Zhengzhou Defrigus Electric Device Co., Ltd.（中国）
• COOL Sarl-FR（フランス）
• Insulet Corporation（米国）
• BD（米国）
• Medtronic（アイルランド）
• Novo Nordisk（デンマーク）
• Sanofi（フランス）
• Roche（スイス）
• Ypsomed（スイス）
• Terumo（日本）
• Abbott Diabetes Care（米国）
• Nipro Corporation（日本）

結論と提言

Insulin Storage Devices Market size was valued at USD 1.0 billion in 2023 and is poised to grow from USD 1.08 billion in 2024 to USD 1.95 billion by 2032, growing at a CAGR of 7.7% during the forecast period (2025-2032).

The market is experiencing robust growth, driven by the rising prevalence of diabetes and the growing adoption of advanced insulin delivery devices. A significant catalyst for this expansion is the increasing demand for innovative insulin storage solutions, spurred by the popularity of insulin pumps necessitating reliable carrying options. Factors such as urbanization, sedentary lifestyles, and unhealthy dietary habits have led to a surge in obesity, a key contributor to diabetes, which the World Obesity Federation predicts will affect one billion people globally by 2030. This increase in diabetes cases will likely boost the demand for insulin storage devices. Notably, type 1 diabetes patients, particularly the 1.52 million individuals under 20, require effective treatment and temperature-sensitive storage solutions to maintain insulin efficacy.

Top-down and bottom-up approaches were used to estimate and validate the size of the Insulin Storage Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Insulin Storage Devices Market Segments Analysis

Global Insulin Storage Devices Market is segmented by Product Type, Patient Type and region. Based on Product Type, the market is segmented into Insulated Kits and Battery Operated Insulin Storage Devices. Based on Patient Type, the market is segmented into Type 1 Diabetes and Type 2 Diabetes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Insulin Storage Devices Market

The rising global prevalence of diabetes, especially in the forms of type 1 and type 2, significantly propels the demand for insulin storage devices, as these tools play a crucial role in managing insulin effectively. With more individuals diagnosed with diabetes each year, the need for reliable and efficient storage solutions becomes increasingly critical. These devices ensure optimal insulin preservation, thereby supporting better health outcomes for patients relying on insulin therapy. As the number of diabetes cases continues to climb, the insulin storage devices market experiences robust growth, reflecting the necessity of these instruments in modern diabetes management strategies.

Restraints in the Insulin Storage Devices Market

The growth of the Insulin Storage Devices market may be hindered by limited availability in low-income countries, primarily due to affordability challenges and insufficient healthcare infrastructure. These factors contribute to a significant barrier, preventing wider access to essential storage devices necessary for effective diabetes management. Consequently, this restricts the potential market expansion in regions where the need is critical but unmet due to economic constraints and a lack of adequate support systems. Addressing these issues will be essential for encouraging growth and improving global access to insulin storage solutions.

Market Trends of the Insulin Storage Devices Market

The Insulin Storage Devices market is witnessing a notable trend towards the adoption of smart and connected devices powered by Internet of Things (IoT) technology. These innovative solutions provide features such as real-time temperature monitoring, which ensures insulin stability and efficacy, along with timely reminders for medication management. Furthermore, the capability to sync with smartphones enhances user experience by allowing remote access to critical data, promoting adherence to treatment regimens. As diabetic patients increasingly seek convenience and reliability, the demand for these technologically advanced storage solutions is set to rise, driving growth and innovation within the market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Insulin Storage Devices Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Insulated Kits
• Battery Operated Insulin Storage Devices

Global Insulin Storage Devices Market Size by Patient Type & CAGR (2025-2032)

• Market Overview
• Type 1 Diabetes
• Type 2 Diabetes

Global Insulin Storage Devices Market Size & CAGR (2025-2032)

• North America (Product Type, Patient Type)
  • US
  • Canada
• Europe (Product Type, Patient Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Patient Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Patient Type)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Patient Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• ReadyCare, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DISONCARE (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medicool (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tawa Outdoor (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cooluli (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arkray, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zhengzhou Olive Electronic Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zhengzhou Defrigus Electric Device Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• COOL Sarl-FR (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insulet Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Nordisk (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Diabetes Care (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations